The top advisor of the Trump administration’s Operation Warp Speed predicted on Tuesday that Johnson & Johnson would seek approval for its COVID-19 vaccine candidate later this month.
Dr. Moncef Slaoui said that he anticipated that the pharmaceutical giant would have enough data from its late-stage trials to apply for emergency use authorization from the Food and Drug Administration in late January.
“If [the] submission is happening at the end of January, one could…
Click here to view the original article.
